Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Large & Mid Cap Fund median (36 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 02 Jan 2013 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty Midcap 150 history starts 14 Jan 2019, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Bandhan Large & Mid Cap Fund |
|---|---|
| 02 Jan 2013 | ₹100.00 |
| 21 Feb 2014 | ₹99.73 |
| 12 Apr 2015 | ₹149.33 |
| 31 May 2016 | ₹142.95 |
| 19 Jul 2017 | ₹195.75 |
| 07 Sep 2018 | ₹219.37 |
| 27 Oct 2019 | ₹208.03 |
| 15 Dec 2020 | ₹245.00 |
| 03 Feb 2022 | ₹345.16 |
| 25 Mar 2023 | ₹345.32 |
| 12 May 2024 | ₹565.95 |
| 01 Jul 2025 | ₹682.09 |
| 20 Aug 2026 | ₹730.08 |
| Metric | Bandhan · Direct NAV ₹167.51 Very High risk ★★★★☆ | Category median Large & Mid Cap Fund · 36 funds |
|---|---|---|
| +6.46% | +6.71% | |
| +20.12% | +16.28% | |
| +18.42% | +15.15% | |
| +16.55% | +15.07% | |
| +15.70% | +15.33% | |
| +17.99% | — | |
| +17.46% | +17.48% | |
| +16.53% | +16.77% | |
| +16.96% | +16.31% | |
| Risk | ||
| 14.29% | 14.81% | |
| 0.95 | 0.61 | |
| 1.29 | 0.82 | |
| -38.54% | -35.67% | |
| Nifty Midcap 150 | — | |
| +3.57% | +0.30% | |
| 0.86 | 0.83 | |
| 92.5% | 84.1% | |
| 72.3% | 78.7% | |
| 1.24% | 1.07% | |
| ₹19,777Cr | ₹3,576Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹100 | — | |
| ₹1.00K | — | |
| 18% | 42% | |
| Manish Gunwani · 3.6y | — | |
| 02 Jan 2013 | — | |
| 128 | — | |
| 26.7% | — | |
| 4.1% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.